“…In the current investigation, integrated bioinformatics methods assisted in an analysis of how key genes change in their expression to uncover potential DKD based on NGS dataset (GSE217709), and we identified total 958 DEGs, including 479 up regulated genes and 479 down regulated genes. [115], FGFR2 [116], ROR2 [117], RTN1 [118], NOTCH3 [119], JAK3 [120], IL18 [121], COL4A1 [122], CEBPD (CCAAT enhancer binding protein delta) [123], KIF26B [124], HES1 [125], CBS (cystathionine beta-synthase) [126], EGF (epidermal growth factor) [127], TRPM2 [128], HSPG2 [129], NOX4 [130], MYH9 [131], GLIS2 [132], TRPV4 [133], GSN (gelsolin) [134], DUSP2 [135], LRP5 [136], CD248 [137], GLI1 [138], PIM1 [139], TGFB3 [140], MDK (midkine) [141], TRPC6 [142], NKD2 [143], NUAK1 [144], CYS1 [145], POSTN (periostin) [146], STAT4 [147], AEBP1 [148] and NNMT (nicotinamide N-methyltransferase) [149] might be a possible genetic markers for susceptibility to renal fibrosis. MMP12 [150], BMP2 [151], IL33 [152], SORCS1 [153], IRF4 [154], PENK (proenkephalin) [77], mellitus.…”